Physician profile
Michael Perez
NPI 1568691780
$5,658.95
in general payments reported to CMS, 2019-2025
31 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $1,202 · 2021: $117 · 2022: $1,466 · 2023: $887 · 2024: $569 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,158.54 | 2019-2025 | Accolade, Triathlon, Mako |
| Smith+Nephew, INC. | $1,302.99 | 2019-2025 | Legion Revision, Pico 14, Real Intelligence |
| Medinc of Texas | $1,066.75 | 2020 | |
| Miach Orthopaedics, INC. | $139.81 | 2024 | |
| Horizon Therapeutics Plc | $110.03 | 2019-2022 | |
| Depuy Synthes Sales INC. | $93.42 | 2021-2025 | Inhance, Trumatch, Orthovisc |
| Aroa Biosurgery Incorporated | $77.00 | 2024 | |
| Pacira Therapeutics, INC. | $75.88 | 2019-2020 | |
| Heraeus Medical, LLC. | $57.25 | 2019 | |
| Heron Therapeutics, INC. | $56.88 | 2021-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $45.41 | 2023-2025 | Exparel, Zilretta |
| Vertex Pharmaceuticals Incorporated | $44.30 | 2025 | |
| Trimed, INC. | $40.13 | 2025 | |
| Baudax Bio INC. | $38.07 | 2021 | |
| Abbott Laboratories | $37.61 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $34.05 | 2023 | Versawrap |
| Kci USA, INC. | $30.14 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $27.75 | 2023 | Seglentis |
| Radius Health, INC. | $25.63 | 2019 | |
| Calliditas Therapeutics US INC. | $21.86 | 2025 | Tarpeyo |
| Linvatec Corporation | $21.76 | 2025 | Biobrace 23mm |
| Ossur Americas, INC. | $20.25 | 2025 | Unloader One X |
| Becton, Dickinson and Company | $19.60 | 2025 | Arista |
| Sonex Health, INC. | $17.32 | 2025 | Sx-One Microknife |
| Orthofix Medical, INC. | $16.25 | 2019 | |
| Arthrosurface Incorporated | $15.84 | 2025 | Ovomotion, Wristmotion Wrist Hemiarthroplasty System |
| Amgen INC. | $15.80 | 2019 | |
| Medtronic USA, INC. | $14.15 | 2019 | |
| Bioventus LLC | $13.65 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.49 | 2020 | |
| Biocomposites INC | $9.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.